Physician experts in diabetes are natural team leaders for managing diabetic patients with foot complications. A position statement from the Italian diabetic foot study group.


Journal

Nutrition, metabolism, and cardiovascular diseases : NMCD
ISSN: 1590-3729
Titre abrégé: Nutr Metab Cardiovasc Dis
Pays: Netherlands
ID NLM: 9111474

Informations de publication

Date de publication:
10 02 2020
Historique:
received: 17 09 2019
revised: 16 11 2019
accepted: 18 11 2019
pubmed: 19 12 2019
medline: 25 8 2020
entrez: 19 12 2019
Statut: ppublish

Résumé

Diabetic foot syndrome (DFS) is a complex disease. The best outcomes are reported with the multi-disciplinary team (MDT) approach, where each member works collaboratively according to his/her expertise. However, which health provider should act as the team leader (TL) has not been determined. The TL should be familiar with the management of diabetes, related complications and comorbidities. He/she should be able to diagnose and manage foot infections, including prompt surgical treatment of local lesions, such as abscesses or phlegmons, in an emergent way in the first meeting with the patient. According to the Organization for Economic Co-operation and Development (OECD) reports, Italy is one of countries with a low amputation rate in diabetic patients. Many factors might have contributed to this result, including 1)the special attention directed to diabetes by the public health system, which has defined diabetes as a "protected disease", and accordingly, offers diabetic patients, at no charge, the best specialist care, including specific devices, and 2)the presence of a network of diabetic foot (DF) clinics managed by diabetologists with medical and surgical expertise. The health care providers all share a "patient centred model" of care, for which they use their internal medicine background and skills in podiatric surgery to manage acute or chronic needs in a timely manner. Therefore, according to Italian experiences, which are fully reported in this document, we believe that only a skilled diabetologist/endocrinologist should act as a TL. Courses and university master's degree programmes focused on DF should guarantee specific training for physicians to become a TL.

Identifiants

pubmed: 31848052
pii: S0939-4753(19)30422-3
doi: 10.1016/j.numecd.2019.11.009
pii:
doi:

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

167-178

Investigateurs

P Calenda (P)
G Federici (G)
O Ludovico (O)
D Simonetti (D)
V Stoico (V)

Informations de copyright

Copyright © 2019 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that no competing interests exist. The authors have disclosed any financial and personal relationships with other people or organizations that could inappropriately influence the work.

Auteurs

R Anichini (R)

Diabetes Unit and Diabetic Foot Unit, Area Pistoiese, AUSL Centro Toscana, Italy.

E Brocco (E)

Diabetic Foot Unit, Foot and Ankle Clinic, Abano Terme Polyclinic, Abano Terme, Italy.

C M Caravaggi (CM)

Diabetic Foot Department, IRCCS Multimedica Milan, Italy.

R Da Ros (R)

Diabetes Center AAS2 Monfalcone-Gorizia, Italy.

L Giurato (L)

Diabetic Foot Unit, Department of Medicine Systems, University of Tor Vergata, Rome, Italy.

V Izzo (V)

Diabetic Foot Unit, Department of Medicine Systems, University of Tor Vergata, Rome, Italy.

M Meloni (M)

Diabetic Foot Unit, Department of Medicine Systems, University of Tor Vergata, Rome, Italy.

L Uccioli (L)

Diabetic Foot Unit, Department of Medicine Systems, University of Tor Vergata, Rome, Italy. Electronic address: luccioli@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH